These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24878683)

  • 1. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department.
    Todd MM; Hindman BJ; King BJ
    Anesth Analg; 2014 Aug; 119(2):323-331. PubMed ID: 24878683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Implementation of Quantitative Electromyographic Neuromuscular Monitoring in an Academic Anesthesia Department: Follow-Up Observations.
    Todd MM; Hindman BJ
    Anesth Analg; 2015 Sep; 121(3):836-838. PubMed ID: 26287308
    [No Abstract]   [Full Text] [Related]  

  • 3. A twitch in time.
    Dutton RP; Donati F
    Anesth Analg; 2014 Aug; 119(2):230-231. PubMed ID: 25046779
    [No Abstract]   [Full Text] [Related]  

  • 4. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Protocol for the Management of Maintenance and Reversal of Rocuronium Block Using Neostigmine or Sugammadex.
    Thilen SR; Liang T; Kruse TN; Cain KC; Treggiari MM; Bhananker SM
    Anesth Analg; 2023 Jun; 136(6):1143-1153. PubMed ID: 37205804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit.
    Murphy GS; Szokol JW; Marymont JH; Greenberg SB; Avram MJ; Vender JS; Nisman M
    Anesthesiology; 2008 Sep; 109(3):389-98. PubMed ID: 18719436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between the flexor hallucis brevis and adductor pollicis muscles in atracurium-induced neuromuscular blockade using acceleromyography: A prospective observational study.
    Le Merrer M; Frasca D; Dupuis M; Debaene B; Boisson M
    Eur J Anaesthesiol; 2020 Jan; 37(1):38-43. PubMed ID: 31592900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study on patterns of neuromuscular blockade reversal.
    Dubovoy T; Housey M; Devine S; Kheterpal S
    BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipsilateral and Simultaneous Comparison of Responses from Acceleromyography- and Electromyography-based Neuromuscular Monitors.
    Nemes R; Lengyel S; Nagy G; Hampton DR; Gray M; Renew JR; Tassonyi E; Fülesdi B; Brull SJ
    Anesthesiology; 2021 Oct; 135(4):597-611. PubMed ID: 34329371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.
    Domenech G; Kampel MA; García Guzzo ME; Novas DS; Terrasa SA; Fornari GG
    BMC Anesthesiol; 2019 Aug; 19(1):143. PubMed ID: 31390986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
    Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
    Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.